Share on LinkedInShare on Twitter

July 20, 2026 06:59 AM EDT

AI

Pharma

Bris­tol My­ers says it will build phar­ma's 'most pow­er­ful' AI su­per­com­put­er with Nvidia

Andrew Dunn

Senior Biopharma Correspondent

Bris­tol My­ers Squibb said Mon­day it will build “the most ad­vanced and en­er­gy-ef­fi­cient AI” su­per­com­put­er sys­tem in the bio­phar­ma in­dus­try, deep­en­ing its re­la­tion­ship with Nvidia.

…

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

Think we're worth reading - tell Google.

Confirm Endpoints as a trusted biopharma news source

Confirm on Google

TRENDING NOW

Can the shin­gles vac­cine pre­vent Alzheimer’s? GSK has a big study to find out

Cel­cu­ity got its can­cer drug ap­proved. Then its stock dipped

GSK drops Phase 3 chron­ic cough drug in a blow to $2B Bel­lus Health buy­out

Q&A: Bet­ty Ti­jms says it’s time to stop treat­ing Alzheimer’s as a sin­gle dis­ease

Ques­tions linger over Bio­gen's tau drug for Alzheimer's, as low dose re­ports bet­ter re­sults

sponsored

HIV Ends Here: In­side Vi­iV Health­care’s Sin­gu­lar Mis­sion

Read Original at Endpoints News →